True Wealth Design
IRWD icon

True Wealth Design’s Ironwood Pharmaceuticals IRWD Stock Holding History

True Wealth Design’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.5K Buy
2,398
+8
+0.3% +$33 ﹤0.01% 1091
2026
Q2 		$10.1K Buy
2,390
+29
+1% +$112 ﹤0.01% 1054
2026
Q1 		$8.29K Hold
2,361
– – ﹤0.01% 1038
2025
Q4 		$7.96K Hold
2,361
– – ﹤0.01% 933
2025
Q3 		$3.09K Buy
2,361
+1,343
+132% +$1.39K ﹤0.01% 1297
2025
Q2 		$731 Buy
1,018
+897
+741% +$704 ﹤0.01% 1593
2025
Q1 		$178 Buy
+121
New +$288 ﹤0.01% 2002
2024
Q4 		– Sell
-112
Closed -$462 – 1440
2024
Q3 		$462 Buy
+112
New +$602 ﹤0.01% 1113

Other funds holding IRWD

CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Range Financial Group
Range Financial Group Tigard, Oregon $361M AUM 58.71% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
Magnus Financial Group
Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return

True Wealth Design's IRWD Position: Q3 2026 in Review

True Wealth Design increased its Ironwood Pharmaceuticals (IRWD) stake by 0.33% in Q3 2026, buying an estimated $33 and bringing the position to 2,398 shares worth $9.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

True Wealth Design first reported a position in IRWD in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.1K in Q2 2026. 28 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • True Wealth Design held 2,398 shares of Ironwood Pharmaceuticals worth $9.5K as of Q3 2026.
  • True Wealth Design bought 8 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $33.
  • Ironwood Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1091 holding.
  • True Wealth Design first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • True Wealth Design's Ironwood Pharmaceuticals position peaked at $10.1K in Q2 2026.
  • 28 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.